Insider · CIK 0001916664

Owens David

Reports to the SEC for 1 company · ATLANTA, GA

sec.gov

Transactions

Companies

Filings

CIK

0001916664

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-19	NXLNexalin Technology, Inc. · Stock Option (right to buy)*A Award	Director, Chief Medical Officer	AAward	+1M sh	—	—	2,484,809
2025-09-29	NXLNexalin Technology, Inc.A Award	Director, Chief Medical Officer	AAward	+36.5K sh	—	—	191,252
2025-09-12	NXLNexalin Technology, Inc. · Stock Option (right to buy)A Award	Director, Chief Medical Officer	AAward	+203K sh	—	—	1,384,809
2025-09-12	NXLNexalin Technology, Inc. · Stock Option (right to buy)A Award	Director, Chief Medical Officer	AAward	+100K sh	—	—	1,484,809
2025-02-26	NXLNexalin Technology, Inc. · Stock Option (right to buy)A Award	Director, Chief Medical Officer	AAward	+140K sh	—	—	139,821
2025-02-26	NXLNexalin Technology, Inc. · Stock Option (right to buy)A Award	Director, Chief Medical Officer	AAward	+654K sh	—	—	794,184
2025-02-26	NXLNexalin Technology, Inc. · Stock Option (right to buy)A Award	Director, Chief Medical Officer	AAward	+125K sh	—	—	919,184
2025-02-04	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,000 sh	$2.98	+$2,980	154,793
2025-02-04	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,000 sh	$3.10	+$3,100	155,793
2025-01-28	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,500 sh	$2.70	+$4,050	153,793
2025-01-23	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,000 sh	$2.70	+$2,700	152,293
2025-01-13	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+2,000 sh	$2.50	+$5,000	151,293
2024-12-20	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,000 sh	$2.75	+$2,750	149,293
2024-11-07	NXLNexalin Technology, Inc. · Stock Option (right to buy)A Award	Director, Chief Medical Officer	AAward	+263K sh	—	—	262,500
2024-10-28	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+500 sh	$2.19	+$1,095	148,293
2024-08-13	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,000 sh	$0.95	+$950	147,793
2024-06-28	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,000 sh	$1.75	+$1,750	146,793
2024-06-18	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,619 sh	$0.71	+$1,149.49	145,793
2024-06-10	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+2,000 sh	$0.65	+$1,300	143,174
2024-06-10	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+1,000 sh	$0.62	+$620	144,174
2022-09-16	NXLNexalin Technology, Inc.P Purchase	Director, Chief Medical Officer	PPurchase	+2,500 sh	$4.15	+$10.4K	141,174
2022-09-16	NXLNexalin Technology, Inc. · Common stock warrantsP Purchase	Director, Chief Medical Officer	PPurchase	+2,500 sh	$0.40	+$1,000	2,500

Recent filings

Accepted (ET)
Dec 234
Owens David0001829126-25-010253
SEC(opens sec.gov)
Sep 304
Owens David0001829126-25-007777
SEC(opens sec.gov)
Sep 124
Owens David0001829126-25-007373
SEC(opens sec.gov)
Feb 274
Owens David0001829126-25-001254
SEC(opens sec.gov)
Feb 54
Owens David0001829126-25-000724
SEC(opens sec.gov)
Feb 44
Owens David0001829126-25-000672
SEC(opens sec.gov)
Jan 295
Owens David0001829126-25-000544
SEC(opens sec.gov)
Jan 294
Owens David0001829126-25-000542
SEC(opens sec.gov)
Jan 244
Owens David0001829126-25-000368
SEC(opens sec.gov)
Oct 304
Owens David0001829126-24-007091
SEC(opens sec.gov)
Aug 154
Owens David0001829126-24-005573
SEC(opens sec.gov)
Jul 14
Owens David0001829126-24-004517
SEC(opens sec.gov)
Jun 214
Owens David0001829126-24-004353
SEC(opens sec.gov)
Jun 124
Owens David0001829126-24-004108
SEC(opens sec.gov)

Companies

Nexalin Technology, Inc.Director, Chief Medical OfficerNXL

Address

4545 HARRIS TRAIL NW

ATLANTA, GA, 30327